Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Acacia Research Corporation Reports Second Quarter 2025 Financial Results

NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) (“Acacia” or the “Company”), which acquires and operates businesses across the industrial, energy and technology sectors, today...

Did the Q2 earnings beat or miss the consensus estimates, and what is the likely impact on the stock price? What potential risks or macro‑economic factors were highlighted that could impact Acadia's performance moving forward? How do Acacia's Q2 results compare to analyst consensus expectations and the broader market outlook?
Symbol: ACTG
Earnings
20 days ago
Read more businesswire

Extreme Networks Reports Fourth Quarter and Fiscal Year 2025 Financial Results

MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks today released financial results for its fourth quarter and fiscal year ended June 30, 2025.

Is there any indication of changes in demand for Extreme Networks' core solutions, such as SD-WAN or AI-driven networking, and how might that affect market share? What macroeconomic factors (e.g., supply chain constraints, enterprise IT spend trends) could influence Extreme Networks' outlook in the coming quarters? How does the company's cash flow and balance sheet strength position it for potential capital return or investment initiatives?
Symbol: EXTR
Earnings
20 days ago
Read more businesswire

CDW Declares Quarterly Cash Dividend of $0.625 Per Share

VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW), a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in...

Will the dividend payout influence the stock's performance relative to sector and market benchmarks? What effect will the dividend have on options pricing, especially near‑term options with ex‑dividend dates? How does this dividend compare to the historical dividend trend for CDW and to its main competitors?
Symbol: CDW
Dividends
20 days ago
Read more businesswire

The New York Times Company Reports Second-Quarter 2025 Results

NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) announced today that its second-quarter 2025 financial results are available on The New York Times Company’s investor relations web...

Is there any guidance on potential acquisitions, divestitures, or strategic initiatives that could affect future growth? What are the implications of the earnings call commentary for future subscription pricing or ad pricing strategy? How does the current valuation (P/E, EV/EBITDA, forward multiples) compare to peers such as Gannett, News Corp, and other media companies?
Symbol: NYT
Earnings
20 days ago
Read more businesswire

NuORDER by Lightspeed and David Jones Deepen Partnership to Propel the Retailer’s Value Chain Transformation Forward

MONTREAL--(BUSINESS WIRE)--NuORDER by Lightspeed, a leading global commerce platform that enables retailers and brands to connect, collaborate, and make smarter buying decisions, announces an expan...

What are the potential risks (e.g., technology integration, data privacy, or reliance on a single large retailer) that could affect Lightspeed’s valuation? Are there any upsell or cross‑sell opportunities with other brands or retailers that could arise from this partnership? Will the partnership drive higher average order value (AOV) or lower inventory turnover days for David Jones, and how will that reflect on Lightspeed’s performance metrics?
Symbol: LIGHT
Partnership
20 days ago
Read more businesswire

NRG Energy, Inc. Reports Second Quarter Results and Reaffirms 2025 Financial Guidance

HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE: NRG) today announces financial results for the second quarter ended June 30, 2025 and reports GAAP Net Loss of $(104) million, GAAP Earnings per Sh...

What potential short‑term trading opportunities arise from the earnings surprise and the sentiment score of –15? Are there any segment or geographic performance details that explain the divergence between GAAP and non‑GAAP results? How does the reaffirmed 2025 guidance align with consensus analyst expectations and the current market consensus?
Symbol: NRG
Earnings
20 days ago
Read more businesswire

Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSÂź platform to develop in vivo gene editing ther...

Are there any hedging or short‑position opportunities based on the disclosed data? How might this affect the competitive landscape with other CRISPR/Cas‑based hepatitis B candidates? Does the release provide any insight into manufacturing scalability and cost of goods for the therapy?
Symbol: DTIL
Clinical trials
20 days ago
Read more businesswire

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported fi...

Are there any notable M&A, partnership, or licensing activities announced in the press release? How does Geron's performance and valuation compare to other biotech companies focused on hematological malignancies? What are the key risks highlighted in the earnings release, and how might they affect future performance?
Symbol: GERN
Earnings
20 days ago
Read more businesswire

Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-m...

How might the market react to any qualitative insights shared by Dr. Brady regarding strategic direction or commercial potential? Will the conference reveal any expansion of Aldeyra’s therapeutic focus beyond immunology and metabolism into eye diseases? Could any forward‑looking statements disclosed in the chat impact the company’s risk profile or valuation?
Symbol: ALDX
Corporate
20 days ago
Read more businesswire

Dine Brands Global, Inc. Reports Second Quarter 2025 Results

PASADENA, Calif.--(BUSINESS WIRE)--Dine Brands Global, Inc. (NYSE: DIN) (the “Company” or “Dine Brands”), the parent company of Applebee’s Neighborhood Grill + Bar¼, IHOP¼ and Fuzzy’s Taco Shop¼ re...

Are there any red flags in the accounting or reporting that could affect the reliability of the reported results? What is the analyst consensus rating and target price adjustments following the release? Is there any guidance or insight on the macro‑economic factors (e.g., consumer spending, inflation) that could affect future performance?
Symbol: DIN
Earnings
20 days ago
Read more businesswire